← Eichor
Condition: Neisseria Meningitidis Serogroup B Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neisseria Meningitidis Serogroup B

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase I Clinical Trial to Assess the Safety and Immunogenicity of DX-104
Phase 1 · 1 location(s) · Shanghai Yuguan Biotech Co., Ltd.（Delonix Bioworks) · NCT07395739MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults
Phase 4 · 2 location(s) · Emory University · NCT07197762
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.